pancreatic cancer
FDA Grants Accelerated Approval to Bizengri for NSCLC and Pancreatic Adenocarcinoma
The FDA granted accelerated approval to Bizengri for indications in NSCLC and pancreatic adenocarcinoma.
DECEMBER 5, 2024
New-Onset Diabetes Is an Early Clue to Pancreatic Cancer
New-onset diabetes in adults older than 50 years of age could be a manifestation of pancreatic cancer, according to ...
SEPTEMBER 23, 2024
Onivyde Approved for First-Line Treatment of Metastatic Pancreatic Adenocarcinoma
The FDA approved Onivyde with oxaliplatin, fluorouracil and leucovorin for the first-line treatment of metastatic ...
FEBRUARY 14, 2024
Dose-Reduced Chemo Effective in Elderly Patients
In a single-center study of elderly patients with advanced pancreatic cancer, reductions in the dose of gemcitabine ...
OCTOBER 8, 2019
Load more